{"id":77,"date":"2020-07-07T09:44:25","date_gmt":"2020-07-07T16:44:25","guid":{"rendered":"https:\/\/depts.washington.edu\/deworm3\/?page_id=77"},"modified":"2024-04-21T20:23:34","modified_gmt":"2024-04-22T03:23:34","slug":"study-progress","status":"publish","type":"page","link":"https:\/\/depts.washington.edu\/deworm3\/about\/study-progress\/","title":{"rendered":"Study Progress"},"content":{"rendered":"

DeWorm3 established three trial sites in Benin, India, and Malawi in strategic partnership with collaborators, including the Ministry of Health<\/a>, Institut de Recherche Clinique du B\u00e9nin (IRCB), and\u00a0Institut de Recherche pour le D\u00e9veloppement (IRD)<\/a>\u00a0in Benin;\u00a0Christian Medical College (CMC), Vellore<\/a>\u00a0in India; and\u00a0Blantyre Institute for Community Outreach (BICO)<\/a>,\u00a0London School of Hygiene and Tropical Medicine (LSHTM)<\/a>,\u00a0Ministry of Health<\/a>\u00a0and\u00a0Ministry of Education, Science, and Technology<\/a>\u00a0in Malawi.\u00a0 Each site has unique epidemiological, cultural, socio-economic, and geographical differences that will enable our team to determine which factors are critical to the interruption of soil-transmitted helminth (STH) transmission.<\/p>\n

In 2018, deworming activities launched in the three trial sites.\u00a0 We conducted a census at each trial site to register more than 370,000 people combined and to assess relevant STH transmission factors, such as access to clean water and sanitation, recent deworming, and other key demographic characteristics.\u00a0 To determine the baseline STH infection status in each area, we asked a random sample of individuals to provide stool samples.\u00a0 These individuals will continue providing stool samples annually and again two years after the trial concludes to assess the rate of change of STH prevalence in each site.<\/p>\n